Primary Health Properties: Merging for Scale, Deleveraging via Joint Ventures
H1 2026 results show merger synergies, rental growth, and a new private hospital JV to fund growth.
PHP.L · Earnings Call · 2026-07-30
Merger Synergies and Integration
Primary Health Properties delivered a robust set of interim results for H1 2026, with adjusted earnings per share up 9% to 3.8p and a 30th consecutive year of dividend growth. The headline story, however, is the execution of the transformational merger with Assura. The combined group is now seeing the benefits of scale: the EPRA cost ratio has fallen from around 10% to 8.7%, and over 90% of the £9 million in cost synergies have been delivered. As CFO Richard Howell put it, “The group's average cost of debt remains broadly unchanged at a low 3.8% and is expected to fall further to 3.5% in the second half of the year once we have completed the deleveraging activities.” — Richard Howell, Chief Financial Officer · 2026-07-30 This financial discipline is embedded in the business model, which CEO Mark Davies described as “delivering strong, secure, recurring, growing cash flows for our shareholders.” — Mark Davies, Chief Executive Officer · 2026-07-30Joint Ventures as a Capital-light Growth Engine
The most significant strategic development is the planned joint venture for the £0.7 billion private hospital portfolio. Terms have been agreed with a global long-term institutional investor, with PHP retaining a 50% stake and acting as asset manager. This structure allows PHP to deleverage while keeping exposure to growth assets and earning management, development, and performance fees. Mark Davies highlighted the optionality: “The agreed terms are for the joint venture to be established on a 50%-50% ownership basis on day 1, with optionality to adjust that ratio in the future, and with PHP acting as the asset manager to the joint venture.” — Mark Davies, Chief Executive Officer · 2026-07-30 This builds on an existing partnership with USS, which has been the vehicle for capital-light development in primary care. The company's pivot toward JVs is a deliberate strategy to fund growth without stretching the balance sheet—a theme consistent with prior commentary. As founder Harry Hyman noted in February 2024, “That would be by way of a joint venture, more than likely with us having a small capital position in the JV rather than us putting it straight onto our balance sheet.” — Harry Hyman, Founder and Chief Executive Officer · 2024-02-28The proceeds from the JV will repay the remaining £260 million of acquisition bridge facilities, and management expects to complete the transaction within weeks. This deleveraging path is central to the investment case, with LTV expected to move into the low 50s and eventually below 50%.This is an important long-term strategic partnership for PHP with a high-quality investor, as well as progressing our deleveraging objective. This will allow us to retain a meaningful financial interest in these growth assets, which are performing well in a resilient market with future growth potential.